# FDA recall D-0011-2023

> **Golden State Medical Supply Inc.** · Class II · drug recall initiated 2022-10-06.

## Product

Rifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDC 51407-323-60), c) 100-count bottle (NDC 51407-323-01), Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH, Packaged by GSMS, Incorporated, CA.

## Reason for recall

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-0011-2023
- **Recalling firm:** Golden State Medical Supply Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-10-06
- **Report date:** 2022-10-26
- **Termination date:** 2025-03-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Camarillo, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0011-2023

## Citation

> AI Analytics. FDA recall D-0011-2023. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0011-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*